The World Rallies Behind Sha’Carri Richardson With Deafening Calls for Cannabis Reform, Green Thumb Closes a Massive Acquisition, and More

[Cannabis Profits Daily]( Thursday, July 08, 2021 [NICI Snippets: Olympic Athletes, Celebrities, and Industry Leaders Rally to Send a Clear Message to D.C. - Cannabis Prohibition Needs to End. Now.]( By Danny Brody Dear Cannabis Profits Daily Reader, Cannabis legalization is inevitable. [This much we know](. And it got a huge push forward when the public and political-sphere - from athletes to celebrities to industry leaders - declared fiery support for Sha'Carri Richardson, the American sprinter who was barred from part of the 2021 Olympic Games in Tokyo after testing positive for THC on a drug test. The positive drug test means Richardson will be unable to compete in her signature 100-yard sprint in Japan later this month, even though Richardson said she was using cannabis to cope with the death of her mother. Her story has prompted a tidal wave of public support, and the consensus is clear: cannabis reform needs to happen. Now. It's already decriminalized throughout the United States, with 18 states allowing adult use and 36 allowing medical, including the state where Richardson tested positive. The fact is that full legalization is inevitable, and cannabis use shouldn't disqualify a professional athlete from competition. Keep reading to see which major political and industry powers announced their support for Richardson in this week's [NICI Snippets]( plus more important industry headlines you may have missed. [It's all right here...]( [trending] [2021 Will Be a Breaking Point for Cannabis Legalization as a Record Number of States Take Matters Into Their Own Hands]( So far in 2021, we've seen more states move on recreational cannabis legalization than any other time in history. But we're just halfway through the year. And there's still a lot more to look forward to for cannabis investors... [Read more]( [Underrated or Overrated? Popular Cannabis Stocks HEXO and Curaleaf Are Put in the Hot Seat to Find Out If They're Worth Your Money]( It's not easy to separate the winners from the wannabes in cannabis. But we know which companies to avoid. In this episode, we put two well-known cannabis companies in the hot seat to show you whether their stocks are worth the hype... [Read more]( [The Top Three Long-Term Profit Plays of the Year]( Tom Gentile's latest trading algorithm, in back testing, uncovered opportunities for 300% in 3 days...471% in 19 days...even 650% in 8 days - all thanks to amateur traders flooding the market with cash. Click below to learn how you can grab your share... [Read more]( [top video] Cannabis Investing Q&A Part One: The Stocks That Should Be in Every Portfolio (And Which to Stay Away From) From Canopy Growth to IIPR to Curaleaf, NICI Executive Director Don Yocham is answering your most pressing questions about which stocks you should drop immediately, which should be in every investor's portfolio, and more... [WATCH]( [our feature benefits] These 20 Small-Cap Stocks Could Bank You 1,000% Returns in 8 Months On the surface, these 20 stocks may seem like they have nothing in common. But thanks to a technology that is only now going fully mainstream, investing $1,000 in each of them could make you $250,000 in the next 8 months... [LEARN MORE]( [stay connected] [facebook]( [twitter]( [instagram]( [National Institute for Cannabis Investors] [Money Morning Red Alert] The best way to receive the most timely, actionable opportunities from Money Morning is by joining our text messaging service, Red Alert - free of charge. [Text INCOME to 21852](sms://21852?&body=INCOME) By texting INCOME to 21852, you are expressly consenting to be texted about investing news, trade alerts and marketing communications from Money Map Press, LLC about Money Morning's Red Alert text messaging service at the phone number you use, even if the phone number is on a corporate, state or national do not call list. You also consent and unconditionally agree to our [Privacy Policy]( and [Terms of Use]( including the arbitration provision and class action waiver contained therein. Your consent is not required to make a purchase. Msgs may be sent using automated technology. Message frequency varies. Msg&data rates may apply. Text HELP for HELP and Text STOP to STOP. You are receiving this e-mail at {EMAIL}, as part of your subscription to Cannabis Profits Daily. To remove your email from this list: [unsubscribe here](. To cancel, or for any other questions or requests, please contact our Customer Service team: [Online]( Phone: 866-260-0361 (North America) 410-777-8270 (International) Mail: Cannabis Profits Daily | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET. © 2021 The National Institute for Cannabis Investors. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: The National Institute for Cannabis Investors. 1125 N Charles Street, Baltimore, MD 21201. [Website]( | [Privacy Policy]( | [Terms & Conditions](